CellPoint Company Profile, Contacts & Intelligence

CellPoint Overview

CellPoint enables clinicians to treat hematological malignancies by retargeting patient immune cells at the point-of-care. In 2022, CellPoint was acquired by Galapagos, a fully integrated biotechnology company. Since then, they have been united around a single purpose: to transform patient outcomes through life-changing science and innovation for more years of life and quality of life. As a result, we will be sharing all company updates, news, and insights on the Galapagos’ page as of now. Please follow Galapagos to stay updated on our latest developments and join our vibrant community. This page will stay online for cv referencing and historic purposes but will not be used to communicate updates. For details on the acquisition, please read our press release from 22 June 2022: https://www.glpg.com/press-release/3637/galapagos-to-acquire-cellpoint-and-aboundbio-to-accelerate-access-to-next-generation-cell-therapies

Headquarters

Limes 7, Nl

Website

cellpoint.bio

Industry

Biotechnology Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Phone Number

Available in AeroLeads

Company Email

Available in AeroLeads

CellPoint Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

CellPoint People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

CellPoint Workforce Composition

Seniority breakdown across 7 visible profiles.

Compare Similar Companies to CellPoint

Explore companies in related markets and compare their industry and employee estimates.